Effect of enzyme-replacement therapy on gastrointestinal symptoms in fabry disease

European Journal of Gastroenterology and Hepatology

Volumn 16, Issue 10, 2004, Pages 1067-1069

  Hoffmann, Björn ^a   Reinhardt, Dietrich ^a   Koletzko, Berthold ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Fabry disease; Gastrointestinal motility disorders; Intravenous enzyme replacement therapy; Lysosomal globosylceramide storage

Indexed keywords

AGALSIDASE ALFA; ALPHA GALACTOSIDASE;

ABDOMINAL PAIN; ADULT; ANOREXIA; ARTICLE; BODY MASS; BODY WEIGHT; CASE REPORT; CLINICAL FEATURE; CONSTIPATION; DIARRHEA; DRUG RESPONSE; ENZYME REPLACEMENT; FABRY DISEASE; GASTROINTESTINAL DISEASE; GASTROINTESTINAL MOTILITY; GENERAL CONDITION IMPROVEMENT; HEADACHE; HUMAN; MALE; METEORISM; PATHOPHYSIOLOGY; PHYSICAL ACTIVITY; PRIORITY JOURNAL; SYMPTOM; WELLBEING;

ADULT; ALPHA-GALACTOSIDASE; CONSTIPATION; DIARRHEA; FABRY DISEASE; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MALNUTRITION; SWEATING;

EID: 6944241303     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042737-200410000-00020     Document Type: Article

References (18)

1. Peters FP, Vermeulen A, Kho TL Anderson-Fabry's disease: alpha-galactosidase deficiency. Lancet 2001; 357:138-140.
2. MacDermot KD, Holmes A, Miners AH. Anderson-Fabry disease: clinical manifestation and impact of disease in a cohort of 98 hemizygous males. J Med Genet 2001; 38:750-760.
3. Brady RO, Schiffmann R. Clinical features of and recent advances in therapy for Fabry disease J Am Med Assoc 2000; 284:2771-2775.
4. Argoff CE, Barton NW, Brady RO, Ziessman HA. Gastrointestinal symptoms and delayed gastric emptying in Fabry's disease: response to metoclopramide. Nucl Med Commun 1998; 19:887-891.
5. Nelis GF, Jacobs GJA. Anorexia, weight loss, and diarrhea as presenting symptoms of angiokeratoma corporis diffusum (Fabry-Anderson's disease). Dig Dis Sci 1989; 34:1798-1800.
6. Friedman LS, Kirkham SE, Thistlewaite JR, Platika D, Kolodny EH, Schuffler MD. Jejunal diverticulosis with perforation as a complication of Fabry's disease. Gastroenterology 1984; 86:558-563.
7. O'Brien BD, Shnitka TK, McDougall R, Walker K, Costopulos L, Lentle B, et al. Pathophysiologic and ultrastructural basis for intestinal symptoms in Fabry's disease. Gastroenterology 1982; 82:957-962.
8. Bryan A, Knauft RF, Burns WA. Small bowel perforation in Fabry's disease. Ann Intern Med 1977; 86:315-316.
9. Rowe JW, Gilliam JI, Warthin TA. Intestinal manifestation of Fabry's disease. Ann Intern Med 1974; 81:628-631.
10. Flynn DM, Lake BD, Boothby CB, Young EP. Gut lesions in Fabry's disease without a rash. Arch Dis Child 1972; 47:26-33.
11. Cable WJL, Kolodny EH, Adams RD. Fabry disease: impaired autonomic function. Neurology 1982; 32:498-502.
12. Brady RO, Tallmann JF, Johnson WG, Gal AE, Leahy WR, Quirk JM, Debakan AS. Replacement therapy for inherited enzyme deficiency. Use of purified ceramidtrihexosidase in Fabry's disease. N Engl J Med 1973; 289:9-14.
13. Grabowski GA. Gaucher disease: enzymology, genetics, and treatment. In: Harris H, Hirschhorn K (editors): Advances in Human Genetics. New York, Plenum Press; 1993, pp. 377-441.
14. Meikle PJ, Hopwood JJ, Clague AE, Carey WF. Prevalence of lysosomal storage disorders. J Am Med Assoc 1999; 281:249-254.
15. Eng CM, Guffon N, Wilcox WR, Germain DP, Lee P, Waldek S, et al. International Collaborative Fabry Disease Study Group. Safety and efficacy of recombinant human α-galactosidase A replacement therapy in Fabry's disease. N Engl J Med 2001; 345:9-16.
16. Schiffmann R, Kopp JB, Austin HA 3rd, Sabnis S, Moore DF, Weibel T, et al. Enzyme replacement therapy in Fabry disease: a randomized controlled trial. J Am Med Assoc 2001; 285:2743-2749.
17. Pastores GM, Thadhani R. Advances in the management of Anderson-Fabry disease: enzyme replacement therapy. Expert Opin Biol Ther 2002; 2:325-333.
18. Schiffmann R, Murray GJ, Treco D, Daniel P, Sellos-Moura M, Myers M, et al. Infusion of alpha-galactosidase A reduces tissue globotriaosylceramide storage in patients with Fabry disease. Proc Natl Acad Sci USA 2000; 97:365-370.